Science Explorer Back to mapMap
Discussion
Researcher · Leo Pharma (United States) · United States

Karen A. Veverka

Karen A. Veverka publishes mostly in Dermatology, Immunology and Molecular Biology, on topics such as Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases and Estrogen and related hormone effects.

ORCID 0009-0009-9222-192X OpenAlex
World rank
#5,481,898
of 7,710,434 ranked researchers
Rank in United States
#1,383,042
of 1,627,098
Works
39
Citations
726
Citations per work
18.6
h-index
14
i10-index 16Top 31% in Dermatology
Karen A. Veverka

What does Karen A. Veverka research?

Karen A. Veverka's work is mostly in Medicine (34%), Immunology and Microbiology (10%), Biochemistry, Genetics and Molecular Biology (9%).

Everything else: 18 works · 46.3% of their workHealth Sciences: 13 works · 33.9% of their workMedicine: 13 works · 33.9% of their workDermatology: 4 works · 11.3% of their workEpidemiology: 3 works · 8.5% of their workEndocrinology, Diabetes and Metabolism: 3 works · 7.5% of their workRheumatology: 3 works · 6.6% of their workLife Sciences: 8 works · 19.8% of their workImmunology and Microbiology: 4 works · 10.4% of their workImmunology: 4 works · 10.4% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 9.4% of their workMolecular Biology: 4 works · 9.4% of their workTHEIR WORKKaren A. Veverka39works
Life Sciences20%Health Sciences34%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1846.3%
    1. Medicine1333.9%
    1. Immunology and Microbiology410.4%
    2. Biochemistry, Genetics and Molecular Biology49.4%
  1. 1Dermatology11% of their works
  2. 2Immunology10% of their works
  3. 3Molecular Biology9% of their works
  4. 4Epidemiology8% of their works
  5. 5Endocrinology, Diabetes and Metabolism8% of their works
  6. 6Rheumatology7% of their works

Research topics

Which keywords describe Karen A. Veverka's research?

The keywords of their largest research topics: IL-17, TH17 Cells, Filaggrin, Skin Microbiome, Estrogen, Off-Label Drug Use, Pediatric Pharmacokinetics and Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. IL-17111 topic
  2. TH17 Cells111 topic
  3. Filaggrin91 topic
  4. Skin Microbiome91 topic
  5. Estrogen61 topic
  6. Off-Label Drug Use61 topic
  7. Pediatric Pharmacokinetics61 topic
  8. Receptor61 topic
  9. Cost-effectiveness Analysis51 topic
  10. Quality of Life51 topic
  11. Alcohol41 topic
  12. Dermatophytes41 topic
  13. Liver Disease41 topic
  14. Nonmelanoma Skin Cancer41 topic
  15. Onychomycosis41 topic
  16. Skin Cancers41 topic

Where does Karen A. Veverka work?

Karen A. Veverka's main affiliation in the publication record is Leo Pharma (United States), United States.

How many publications and citations does Karen A. Veverka have?

OpenAlex counts 39 works and 726 citations for Karen A. Veverka, an h-index of 14, ranking #5,481,898 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Karen A. Veverka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.